Xcout Intel
Granite Bio competitors & alternatives
The 12 closest competitors and alternatives to Granite Bio among biotech companies — ranked by similarity to what Granite Bio actually does, not by market-cap band.
Subscribe to see Granite Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Granite Bio
Granite Bio is a biotechnology company headquartered in Basel, Switzerland. It is developing first-in-class therapies by targeting fundamentals of biology and debuted with $100 million of capital.
Granite Bio at a glance
Granite Bio is a biotech company headquartered in Switzerland. Xcout tracks 15 named people at Granite Bio, including Patrick Loustau (President and Chief Executive Officer).
Granite Bio leadership
- Patrick LoustauPresident and Chief Executive Officer
- Dominik HartlChief Medical Officer
- Gijs van den BrinkChief Scientific Officer
- Thomas HuberChief Development Officer
- Anja HippHead of CMC, VP
- Jean-Nicolas SchickelHead Immunology Discovery, VP
9 more named people on record for Granite Bio, with roles, board committees and tenure — see the full roster →
Top 12 Granite Bio competitors
Ranked by semantic similarity — how close each company is to Granite Bio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Vaderis Therapeutics AG is a clinical-stage biotechnology company focused on developing novel treatments for severe vascular diseases. The company is headquartered in Basel, Switzerland.
Biotechnology
Mysthera Therapeutics AG is a biotechnology company headquartered in Basel, Switzerland, focused on developing first-in-class, oral therapeutics to treat inflammation-driven and related diseases.
Similar biotech company
Windward Bio is a clinical-stage biotechnology and drug development company headquartered in Basel, Switzerland. It is committed to improving outcomes for people living with serious immunological diseases through its deep discovery, development, and commercialization expertise.
Biotechnology
NBE-Therapeutics is a biotechnology company founded in 2012 and headquartered in Basel, Switzerland, focused on developing antibody-drug conjugates for oncology treatments.
Similar biotech company
Amporin Pharmaceuticals AG is a Swiss biotechnology company founded in Basel in 2024. The firm focuses on developing a new class of small-molecule drugs designed to target toxic membrane mechanisms.
Biotechnology
Ferrosa Therapeutics AG is a Swiss biotechnology company founded in Basel, Switzerland, focusing on developing novel therapeutics to treat anemia and related conditions.
Biotechnology
VAXIMM AG is a biotech company headquartered in Basel, Switzerland, that focuses on developing a new class of cytotoxic immunotherapies and clinical-stage targeted treatments through its subsidiaries.
Biotechnology
LifeMine Therapeutics is a privately held biotechnology company founded in 2017 with headquarters in Watertown, Massachusetts, and an additional location in Switzerland. The company leverages genomic data to accelerate the discovery and development of novel small-molecule medicines.
Similar biotech company
Pretzel Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, advancing a new class of medicines that target cellular energetics and mitochondrial function.
Biotechnology
Allegria Therapeutics is a Swiss biotech company founded in Basel in 2023 that targets mast cells to redefine the treatment of allergic and inflammatory diseases.
Biotechnology
Base Therapeutics is a biotechnology company that develops next-generation gene editing technologies, including its proprietary AccuBase base editing system and enhanced prime editing technology. The company focuses on creating therapeutic solutions for cancer and genetic diseases, alongside engineered immune cell therapies such as BASE-NK and CAR-T products. It serves patients and partners with pharmaceutical and agricultural enterprises by licensing its precision gene editing tools.
Similar biotech company
Octant Bio is a biotechnology company that combines next-generation biology, chemistry, and computation to discover and develop precision small molecule therapeutics. The company targets complex cellular mechanisms to address genetic diseases, such as protein misfolding and mistrafficking across various therapeutic areas including genetic disorders, oncology, metabolism, and immunology.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Granite Bio and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Granite Bioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →